Citations 1
A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma
Sonbol, Mohamad Bassam , Hilal, Talal , Dueck, Amylou C. , Rosenthal, Allison , Conley, Christopher R., Ginos, Brenda, Gano, Katherine, Nichols, Craig S., Leis, José F., Johnston, Patrick B. , Northfelt, Donald W. , Bergsagel, P. Leif , Inwards, David J. , Ansell, Stephen M. , Reeder, Craig B. , Bergsagel, P. Leif , Rosenthal, Allison C, Ginos, Brenda F, Gano, Katherine M, Bergsagel, Peter Leif, Dueck, A. C. , Rosenthal, Allison , Sonbol, Mohamad B , Kosiorek, Heidi , Nichols, Craig, Habermann, Thomas M. , Witzig, Thomas E. , Hilal, Talal
Leukemia & Lymphoma | January 11, 2018 | Volume: 59 | Issue: 9 | Pages: 2128-2134
